Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
- PMID: 36798820
- PMCID: PMC9928151
- DOI: 10.3389/fonc.2023.1138587
Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
Keywords: Neoadjuvant chemo(radio)therapy; borderline resectable pancreatic cancer (BRPC); locally advanced pancreatic cancer (LAPC); lymphnode metastasis; pancreatic cancer.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
References
-
- Allen PJ, Kuk D, Del CCF, Basturk O, Wolfgang CL, Cameron JL, et al. . Multi-institutional validation study of the American joint commission on cancer (8th edition) changes for tand n staging in patients with pancreatic adenocarcinoma. Ann Surg (2017) 265:185–91. doi: 10.1097/SLA.0000000000001763 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
